baclofen has been researched along with Movement Disorders in 23 studies
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intrathecal baclofen reduces spasticity in individuals with cerebral palsy." | 8.79 | Intrathecal baclofen in cerebral palsy movement disorders. ( Albright, AL, 1996) |
| "The aim of this retrospective analysis was to determine the impact of intrathecal baclofen (ITB) therapy on motor function in patients with cerebral palsy (CP)." | 7.77 | Intrathecal baclofen and motor function in cerebral palsy. ( Antonello, CE; Motta, F; Stignani, C, 2011) |
| "For spinal spasticity, they are typically in the order of 100-300 μg/day." | 5.42 | Intrathecal Baclofen therapy in Germany: Proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders Consensus Meeting. ( Berweck, S; Chatzikalfas, A; Dressler, D; Ebke, M; Frank, B; Hesse, S; Huber, M; Krauss, JK; Mücke, KH; Nolte, A; Oelmann, HD; Pickenbrock, H; Saberi, FA; Schmutzler, M; Schönle, PW; Van der Ven, C; Veelken, N; Vogel, M; Vogt, T, 2015) |
| "Treatment of children with movement disorders associated with CP increased slowly in the 1970s and 1980s but accelerated rapidly in the 1990s with the introduction of lumbar dorsal rhizotomies and intrathecal baclofen." | 5.41 | Spasticity and movement disorders in cerebral palsy. ( Albright, AL, 2023) |
| "Intrathecal baclofen reduces spasticity in individuals with cerebral palsy." | 4.79 | Intrathecal baclofen in cerebral palsy movement disorders. ( Albright, AL, 1996) |
| "The aim of this retrospective analysis was to determine the impact of intrathecal baclofen (ITB) therapy on motor function in patients with cerebral palsy (CP)." | 3.77 | Intrathecal baclofen and motor function in cerebral palsy. ( Antonello, CE; Motta, F; Stignani, C, 2011) |
| "To test the efficacy of intrathecal baclofen in various movement disorders, 18 patients with dystonia, head trauma, cerebral palsy, rigidity, or painful spasms underwent a trial of intrathecal baclofen." | 3.69 | Intrathecal baclofen for motor disorders. ( Gianino, JM; Penn, RD; York, MM, 1995) |
| "Baclofen is a GABA-like drug which passes through the blood-brain barrier and which reduces the neuroleptic-induced increase of dopamine turn-over." | 2.64 | Baclofen (Lioresal) in the treatment ofneuroleptic-induced tardive dyskinesia. ( Korsgaard, S, 1976) |
| "A new less invasive treatment of tremor using MR guided focused ultrasound has started and is promising." | 2.49 | [Role of neurosurgical management in movement disorders other than Parkinson disease]. ( Taira, T, 2013) |
| "Children with primary dystonia and those with tremor can be treated with deep brain stimulation of the internal globus pallidus and thalamus, respectively." | 2.42 | Neurosurgical treatment of spasticity and other pediatric movement disorders. ( Albright, AL, 2003) |
| "For spinal spasticity, they are typically in the order of 100-300 μg/day." | 1.42 | Intrathecal Baclofen therapy in Germany: Proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders Consensus Meeting. ( Berweck, S; Chatzikalfas, A; Dressler, D; Ebke, M; Frank, B; Hesse, S; Huber, M; Krauss, JK; Mücke, KH; Nolte, A; Oelmann, HD; Pickenbrock, H; Saberi, FA; Schmutzler, M; Schönle, PW; Van der Ven, C; Veelken, N; Vogel, M; Vogt, T, 2015) |
| "Central pontine and extrapontine myelinolysis (CPEM) are rare conditions usually associated with rapid correction of hyponatremia." | 1.34 | Psychotic disorder in a patient with central and extrapontine myelinolysis. ( Krystal, A; Lim, L, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (21.74) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 7 (30.43) | 29.6817 |
| 2010's | 7 (30.43) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Albright, AL | 3 |
| Assumpcao de Monaco, B | 1 |
| Fruett da Costa, PR | 1 |
| Franceschini, PR | 1 |
| Lake, W | 1 |
| Shah, H | 1 |
| Taira, T | 1 |
| Dressler, D | 1 |
| Berweck, S | 1 |
| Chatzikalfas, A | 1 |
| Ebke, M | 1 |
| Frank, B | 1 |
| Hesse, S | 1 |
| Huber, M | 1 |
| Krauss, JK | 1 |
| Mücke, KH | 1 |
| Nolte, A | 1 |
| Oelmann, HD | 1 |
| Schönle, PW | 1 |
| Schmutzler, M | 1 |
| Pickenbrock, H | 1 |
| Van der Ven, C | 1 |
| Veelken, N | 1 |
| Vogel, M | 1 |
| Vogt, T | 1 |
| Saberi, FA | 1 |
| Faller, KM | 1 |
| Quintana, RG | 1 |
| Fernández-Alvarez, E | 1 |
| Lundy, C | 1 |
| Lumsden, D | 1 |
| Fairhurst, C | 1 |
| Benecke, R | 1 |
| Patejdl, R | 1 |
| Krach, L | 1 |
| Motta, F | 1 |
| Antonello, CE | 1 |
| Stignani, C | 1 |
| Nomura, S | 1 |
| Kagawa, Y | 1 |
| Kida, H | 1 |
| Maruta, Y | 1 |
| Imoto, H | 1 |
| Fujii, M | 1 |
| Suzuki, M | 1 |
| Turner, MS | 1 |
| Roubertie, A | 1 |
| Leydet, J | 1 |
| Rivier, F | 1 |
| Humbertclaude, V | 1 |
| Cheminal, R | 1 |
| Echenne, B | 1 |
| Lim, L | 1 |
| Krystal, A | 1 |
| Marsden, CD | 1 |
| Sheehy, MP | 1 |
| Kirubakaran, V | 1 |
| Mayfield, D | 1 |
| Rengachary, S | 1 |
| Penn, RD | 1 |
| Gianino, JM | 1 |
| York, MM | 1 |
| Korsgaard, S | 1 |
| Tourian, A | 2 |
| Iacono, R | 1 |
| Nashold, B | 1 |
| Urban, B | 1 |
| Sanders, D | 1 |
| Iacono, RP | 1 |
| Linford, J | 1 |
| Sandyk, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pros and Cons of Botulinum Injection Treatment in Cerebral Palsy: A Qualitative Study Examining the Caregiver's Perspectives[NCT04256187] | 21 participants (Actual) | Observational | 2019-11-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
10 reviews available for baclofen and Movement Disorders
| Article | Year |
|---|---|
Spasticity and movement disorders in cerebral palsy.
Topics: Baclofen; Cerebral Palsy; Child; Dystonia; Humans; Movement Disorders; Muscle Relaxants, Central; Mu | 2023 |
Intrathecal Baclofen Infusion for the Treatment of Movement Disorders.
Topics: Baclofen; Humans; Injections, Spinal; Movement Disorders; Muscle Relaxants, Central; Treatment Outco | 2019 |
[Role of neurosurgical management in movement disorders other than Parkinson disease].
Topics: Baclofen; Deep Brain Stimulation; Dystonia; Humans; Injections, Spinal; Movement Disorders; Muscle S | 2013 |
Movement disorders in children: recent advances in management.
Topics: Age Distribution; Age of Onset; Baclofen; Benzodiazepines; Child; Child, Preschool; Cholinergic Anta | 2009 |
Treating complex movement disorders in children with cerebral palsy.
Topics: Baclofen; Botulinum Toxins; Cerebral Palsy; Deep Brain Stimulation; Humans; Infusion Pumps, Implanta | 2009 |
[New therapies for spastic movement disorders].
Topics: Administration, Oral; Baclofen; Botulinum Toxins, Type A; Cannabinoids; Clonidine; Diazepam; Humans; | 2009 |
Neurosurgical treatment of spasticity and other pediatric movement disorders.
Topics: Athetosis; Baclofen; Child; Chorea; Dystonia; Electric Stimulation Therapy; GABA Agonists; Humans; I | 2003 |
Intrathecal drug delivery 2002.
Topics: Baclofen; Drug Approval; Humans; Infusion Pumps, Implantable; Injections, Spinal; Morphine; Movement | 2003 |
[Movement disorders in childhood: therapeutic update].
Topics: Anti-Dyskinesia Agents; Baclofen; Botulinum Toxins, Type A; Child; Consensus; Electric Stimulation T | 2004 |
Intrathecal baclofen in cerebral palsy movement disorders.
Topics: Baclofen; Cerebral Palsy; Health Care Costs; Humans; Infusion Pumps, Implantable; Injections, Spinal | 1996 |
2 trials available for baclofen and Movement Disorders
| Article | Year |
|---|---|
GABA and movement disorders.
Topics: Anticonvulsants; Baclofen; Clinical Trials as Topic; Double-Blind Method; Dyskinesia, Drug-Induced; | 1981 |
Baclofen (Lioresal) in the treatment ofneuroleptic-induced tardive dyskinesia.
Topics: Aged; Aminobutyrates; Baclofen; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Middle Ag | 1976 |
11 other studies available for baclofen and Movement Disorders
| Article | Year |
|---|---|
Intracerebroventricular baclofen therapy improves function and quality of life in a child with severe cerebral palsy.
Topics: Baclofen; Cerebral Palsy; Child; Humans; Infusion Pumps, Implantable; Movement Disorders; Muscle Rel | 2023 |
Intrathecal Baclofen therapy in Germany: Proceedings of the IAB-Interdisciplinary Working Group for Movement Disorders Consensus Meeting.
Topics: Baclofen; Germany; Humans; Infusion Pumps, Implantable; Injections, Spinal; Movement Disorders; Musc | 2015 |
Movement disorder in young weimaraners.
Topics: Age of Onset; Animals; Baclofen; Diazepam; Dog Diseases; Dogs; Movement Disorders; Quality of Life; | 2016 |
Intrathecal baclofen and motor function in cerebral palsy.
Topics: Baclofen; Cerebral Palsy; Humans; Injections, Spinal; Movement Disorders | 2011 |
Intrathecal baclofen and motor function in cerebral palsy.
Topics: Adolescent; Adult; Age Factors; Baclofen; Cerebral Palsy; Child; Child, Preschool; Disability Evalua | 2011 |
Effects of intrathecal baclofen therapy on motor and cognitive functions in a rat model of cerebral palsy.
Topics: Animals; Animals, Newborn; Baclofen; Cerebral Palsy; Cognition Disorders; Electric Stimulation; Evok | 2012 |
Psychotic disorder in a patient with central and extrapontine myelinolysis.
Topics: Antidepressive Agents, Second-Generation; Antiparkinson Agents; Antipsychotic Agents; Baclofen; Fema | 2007 |
Dyskinesia and psychosis in a patient following baclofen withdrawal.
Topics: Adult; Baclofen; Humans; Male; Movement Disorders; Muscle Spasticity; Pain; Paraplegia; Psychoses, S | 1984 |
Intrathecal baclofen for motor disorders.
Topics: Adolescent; Adult; Baclofen; Cerebral Palsy; Craniocerebral Trauma; Dystonia; Female; Humans; Inject | 1995 |
Involuntary movements of the lower extremity following dorsal root entry zone lesions in a man treated for phantom limb pain.
Topics: Baclofen; Humans; Leg; Male; Middle Aged; Movement Disorders; Phantom Limb; Spinal Nerve Roots | 1988 |
Baclofen in the treatment of post-amputation autonomous stump movements.
Topics: Amputation, Surgical; Baclofen; Humans; Male; Middle Aged; Movement Disorders; Postoperative Complic | 1987 |